Join to apply for the Director, Analytical Development role at Revolution Medicines
Revolution Medicines is a clinical‑stage precision oncology company focused on developing novel targeted therapies to inhibit frontier RAS‑addicted cancers. Its R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion In schnell inhibitors for use in combination ......
#J-18808-Ljbffr